|15.61||-0.385 / -2.41%|
As of 3:59pm ET
|15.62||+0.015 / +0.10%|
The 5 analysts offering 12-month price forecasts for Theravance Inc have a median target of 15.00, with a high estimate of 18.00 and a low estimate of 7.00. The median estimate represents a -3.88% decrease from the last price of 15.61.
The current consensus among 6 polled investment analysts is to Hold stock in Theravance Inc. This rating has held steady since July, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.